You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Differentiated Thyroid Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrence in Patients With Differentiated Thyroid Cancer

Not yet recruiting
  • Differentiated Thyroid Cancer
  • (no location specified)
Nov 30, 2023

Differentiated Thyroid Cancer Trial in Shanghai (surufatinib)

Recruiting
  • Differentiated Thyroid Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 9, 2023

Differentiated Thyroid Cancer Patients Treated With Different

Not yet recruiting
  • Thyroid Cancer
  • (no location specified)
Nov 15, 2023

Differentiated Thyroid Cancer, Pediatric Cancer, Cancer Trial (Larotrectinib monotherapy, 131I therapy)

Not yet recruiting
  • Differentiated Thyroid Cancer
  • +3 more
  • Larotrectinib monotherapy
  • 131I therapy
  • (no location specified)
Mar 13, 2023

Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma Trial in Beijing (Anlotinib Hydrochloride

Not yet recruiting
  • Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma
  • Anlotinib Hydrochloride Capsule and Penpulimab
  • Beijing, Beijing, China
    YansongLin
Sep 25, 2023

Thyroid Cancer Trial in Medellin (Traditional neck dissection approach, Anterior neck dissection approach)

Recruiting
  • Thyroid Cancer
  • Traditional neck dissection approach
  • Anterior neck dissection approach
  • Medellin, Antioquia, Colombia
    Hospital Alma Mater de Antioquia
Nov 20, 2023

Efficacy of Lenvatinib in Differentiated Thyroid Cancer

Recruiting
  • Differentiated Thyroid Cancer
  • Gender
  • Rome, Italy
    Regina Elena National Cancer Institute
Mar 16, 2023

Differentiated Thyroid Cancer Trial in China (AL2846 capsule)

Recruiting
  • Differentiated Thyroid Cancer
  • AL2846 capsule
  • Guilin, Guangxi, China
  • +3 more
Feb 27, 2023

Quality of Life in Differentiated Thyroid Carcinoma Undergoing

Not yet recruiting
  • Thyroid Cancer
  • minimally invasive procedure
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hopsital
Sep 13, 2023

Thyroid Cancer Trial run by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (drug, radiation,

Recruiting
  • Thyroid Cancer
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 28, 2023

Differentiated Thyroid Cancer Trial in Beijing (Recombinant Human Thyroid Stimulating Hormone for Injection(rhTSH), radioactive

Recruiting
  • Differentiated Thyroid Cancer
  • Recombinant Human Thyroid Stimulating Hormone for Injection(rhTSH)
  • radioactive iodine
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Nov 28, 2022

Differentiated Thyroid Cancer Trial in Pavia (Pembrolizumab)

Not yet recruiting
  • Differentiated Thyroid Cancer
  • Pavia, Lombardia, Italy
    Istituti Clinici Scientifici Maugeri
May 5, 2023

18F-TFB PET/CT Scan in Differentiated Thyroid Cancer

Recruiting
  • Differentiated Thyroid Gland Carcinoma
  • +2 more
  • Computed Tomography
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Differentiated Thyroid Cancer Trial in Spain (Cabozantinib)

Not yet recruiting
  • Differentiated Thyroid Cancer
  • Oviedo, Asturias, Spain
  • +9 more
Dec 14, 2022

Differentiated Thyroid Cancer Trial (Low iodine diet)

Not yet recruiting
  • Differentiated Thyroid Cancer
  • Low iodine diet
  • (no location specified)
Oct 25, 2022

Thyroid Tumor Follicular, Bone Metastases Trial in Beijing (Sr-89)

Not yet recruiting
  • Thyroid Neoplasm Follicular
  • Bone Metastases
  • Beijing, China
    Peking Union Medical College Hospital
Jul 18, 2022

Differentiated Thyroid Cancer, Thyroid Cancer, Nonmedullary Trial in La Roche-sur-Yon, Nantes (WGS)

Recruiting
  • Differentiated Thyroid Cancer
  • Thyroid Cancer, Nonmedullary
  • WGS
  • La Roche-sur-Yon, France
  • +1 more
Feb 25, 2022

Thyroid Cancer Trial in Washington (99mTc sestamibi)

Terminated
Has Results
  • Thyroid Cancer
  • 99mTc sestamibi
  • Washington, District of Columbia
    Washington Hospital Center
Jul 5, 2022

Reminder System (TCARS) Study - A Pilot Study.

Not yet recruiting
  • Low Risk Differentiated Thyroid Cancer
  • Shared-care model
  • (no location specified)
Aug 18, 2022

Thyroglobulin and Galectin-3 for Prognosis and Follow-up in

Recruiting
  • Thyroid Cancer
  • +2 more
    • Taipei, Taiwan
      Chih-Yuan Wang, M.D
    Oct 16, 2022

    Thyroglobulin Point of Care Assay for Rapid Detection of

    Recruiting
    • Differentiated Thyroid Cancer
    • Lymph Node Metastases
    • Point of care assay for thyroglobulin (POC-Tg) evaluation of a suspected cervical lymph node
    • Ashkelon, Israel
    • +2 more
    Oct 25, 2022

    Thyroid Cancer Trial in Suita (Targeted alpha therapy)

    Recruiting
    • Thyroid Cancer
    • Targeted alpha therapy
    • Suita, Japan
      Osaka University Hospital
    Mar 2, 2022

    Radioactive Iodine-refractory Differentiated Thyroid Cancer Trial in Beijing (Camrelizumab combination with Apatinib)

    Recruiting
    • Radioactive Iodine-refractory Differentiated Thyroid Cancer
    • Camrelizumab combination with Apatinib
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Jan 18, 2022

    DTC - Differentiated Thyroid Cancer Trial in Beijing (Anlotinib HCl)

    Recruiting
    • DTC - Differentiated Thyroid Cancer
    • Anlotinib hydrochloride
    • Beijing, China
      Peking Union Medical College Hospital
    Jan 18, 2022

    Thyroid Cancer Trial in Peking (Apatinib)

    Completed
    • Thyroid Cancer
    • Peking, China
      Peking Union Medical College Hospital
    Jan 18, 2022